An appeal by Johnson & Johnson to overturn a $124 million verdict against the company has been rejected by the U.S. Supreme Court. The verdict involved the pharmaceutical giant’s drug Risperdal, an atypical antipsychotic the state of South Carolina alleged was illegally marketed by the company. Lawsuit alleges deceptive marketing... Read more »

A settlement has been reached between the Kentucky Attorney General and Johnson & Johnson regarding the schizophrenia drug Risperdal. The lawsuit was originally filed with allegations that the pharmaceutical giant and its subsidiary Janssen Pharmaceuticals hid some of the drug’s side effects from consumers, while marketing it for off-label use... Read more »

A man has been awarded $1.75 million by a jury that determined his breast growth was caused by his use of Risperdal as a child. This is the fourth trial involving the link between Risperdal and male breast growth. The first two also resulted in decisions favoring the plaintiffs and the... Read more »

The FDA has issued a safety communication involving potentially dangerous side effects associated with a category of type 2 diabetes drugs known as SGLT2 inhibitors. The agency has warned that use of the drug could lead to ketoacidosis, a serious condition often requiring emergency medical care. Urinary tract infections or... Read more »

A plaintiff who recently filed a lawsuit against Invokana manufacturers Janssen Pharmaceuticals and Johnson & Johnson claims use of the drug to treat type 1 diabetes led to serious kidney damage. The lawsuit further accuses the companies of failing to warn consumers and the medical community about the risk associated with... Read more »

As concern over risks associated with the type 2 diabetes drug Invokana continues to rise, a new study has shown the same dangers seen with the drug in type 2 diabetes patients may also be present in those with type 1 diabetes. Researchers have found that off-label use of this... Read more »

A plaintiff who filed a lawsuit against multiple manufacturers of testosterone therapy products claims use of Testim and Androgel led to his heart attack in 2013. The plaintiff has joined more than 3,000 other plaintiffs with similar allegations. Those lawsuits have been coordinated into multidistrict litigation in Illinois District Court. The plaintiff... Read more »

A 15-chapter expose on Johnson & Johnson by a Huffington Post reporter reveals how J&J’s drug Risperdal became a blockbuster product for the company. This drug was approved by the FDA in 1993 to treat severe mental disorders like bipolar disorder and schizophrenia. However, Risperdal has also been prescribed off-label to... Read more »

Four bellwether trials have been scheduled in the ongoing coordinated proceedings underway involving the blood-thinning medication Xarelto. The judge overseeing the coordination has put four trials on the calendar in the first half of 2017, which will provide valuable insight into how subsequent Xarelto lawsuits may be resolved. All of... Read more »

Another Granuflo lawsuit involving a wrongful death has been filed in the coordinated proceedings currently underway in U.S. District Court in Massachusetts. This plaintiff has filed a complaint on behalf of a deceased family member who died after receiving dialysis treatment using Granuflo or Naturalyte products manufactured by Fresenius. The... Read more »